These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Pharmacologic treatment of a case of Crigler-Najjar syndrome]. Lupi L; Di Tullio MT Pathologica; 1972; 64(931):223-6. PubMed ID: 4671380 [No Abstract] [Full Text] [Related]
9. [New indications for phenobarbital in pediatrics]. Windorfer A Med Welt; 1975 Aug; 6(35):1524-6. PubMed ID: 1177740 [No Abstract] [Full Text] [Related]
10. [The pros and cons of luminal teatment of hyperbilirubinemia]. Lüders D Monatsschr Kinderheilkd (1902); 1970 Mar; 118(3):94-102. PubMed ID: 4333560 [No Abstract] [Full Text] [Related]
11. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency: evidence for genetic heterogeneity. Arias IM; Gartner LM; Cohen M; Ben-Ezzer J; Levi AJ Trans Assoc Am Physicians; 1968; 81():66-75. PubMed ID: 5729564 [No Abstract] [Full Text] [Related]
12. Treatment of Gilbert's syndrome with phenobarbitone. Black M; Sherlock S Lancet; 1970 Jun; 1(7661):1359-61. PubMed ID: 4195058 [No Abstract] [Full Text] [Related]
13. Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus. Crigler JF; Gold NI J Clin Invest; 1969 Jan; 48(1):42-55. PubMed ID: 5765026 [TBL] [Abstract][Full Text] [Related]
14. Crigler-Najjar syndrome type II caused by a homozygous triple mutation [T-3279G, A(TA)7TAA, and H39D] of UGT1A1. Maruo Y; Topaloglu AK; Takahashi H; Mori A; Iwai M; Duzovali O; Yamamoto K; Matui K; Sato H; Takeuchi Y J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):236-9. PubMed ID: 16456422 [No Abstract] [Full Text] [Related]
15. Proceedings: Prolonged survival in the Crigler-Najjar syndrome: ultrastructural and dietary studies. Gollan JL; Huang SN; Billing BH; Sherlock S Gut; 1974 Oct; 15(10):838. PubMed ID: 4434967 [No Abstract] [Full Text] [Related]
16. Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Pett S; Mowat AP Mol Aspects Med; 1987; 9(5):473-82. PubMed ID: 3306242 [No Abstract] [Full Text] [Related]
17. Inheritance of type 2 Crigler-Najjar hyperbilirubinaemia. Hunter JO; Thompson RP; Dunn PM; Williams R Gut; 1973 Jan; 14(1):46-9. PubMed ID: 4692254 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of Crigler-Najjar's congenital familial non-hemolytic jaundice with kernicterus]. Plöchl E; Hohenwallner W Wien Med Wochenschr; 1978 Feb; 128(3):70-3. PubMed ID: 75612 [No Abstract] [Full Text] [Related]
19. [The d-glucaric acid test in the evaluation of the inductive properties of phenobarbital and spironalactone]. Del Ninno E; Tornaghi G; Tripodi A; Colombo M Acta Vitaminol Enzymol; 1974; 28(5):203-6. PubMed ID: 4480343 [No Abstract] [Full Text] [Related]
20. Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gollan JL; Huang SN; Billing B; Sherlock S Gastroenterology; 1975 Jun; 68(6):1543-55. PubMed ID: 805737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]